Table 1. Demographic and clinical characteristics of study participants.
| Variable | Frequency (%) |
|---|---|
| Age | |
| <1 month | 53 (13.2) |
| 1–14 years | 158 (39.3) |
| 15–46 | 113 (28.1) |
| >46 | 78 (19.4) |
| Sex | |
| Male | 235 (58.5) |
| Female | 167 (41.5) |
| Ward | |
| Pediatric | 164 (40.8) |
| Surgical | 79 (19.7) |
| Medical | 91 (22.6) |
| ICU | 68 (16.9) |
| Antibiotic use before culture | |
| Yes | 232 (57.7) |
| No | 170 (42.3) |
| Antibiotics administered before culture | |
| Ceftriaxone | 127 (31.6) |
| Ampicillin/Gentamicin | 21 (5.2) |
| Amoxycillin-clavulanic acid | 21 (5.2) |
| Meropenem | 31 (7.7) |
| Ciprofloxacin/Vancomycin | 18 (4.5) |
| Others | 14 (3.4) |
| No | 170 (42.3) |
| Underlying diseases | |
| Malignant | 93 (23.1) |
| Kidney diseases | 55 (13.7) |
| Sepsis | 131 (32.6) |
| Stroke/post-surgery/Diabetes mellitus | 76 (18.9) |
| Others | 47 (11.7) |
| Outcome | |
| Death | 87 (21.8) |
| Discharged | 315 (78.1) |